Skip to main content
TipRanks
Go Ultimate75% OFF

Nugl (NUGL) AI Stock Analysis

20 Followers
NUGL

Nugl

(Other OTC:NUGL)

Select Model
Rating:65Neutral
Price Target:$0.01â–²(816.67% Upside)
Action:reiterated
Date:11/20/26

The overall score of 65 reflects a company in the midst of a significant operational turnaround, which is the most impactful factor. Financial performance is the primary driver, with impressive revenue growth, positive operating income, and strong free cash flow generation. However, the score is tempered by the nascent nature of this recovery—net income is still negative—and a lack of confirming technical or earnings call data. The low P/E ratio offers a potential value opportunity, but this is less meaningful given the company's early-stage profitability and penny stock status.

Positive Factors
Revenue Growth and Gross MarginRapid revenue expansion combined with a stable gross margin indicates that growth has not yet required substantial erosion in unit economics. If maintained, this combination can broaden the operating base, support reinvestment, and provide a foundation for improving profitability over the next several quarters.
Negative Factors
Unestablished ProfitabilityThe company has not yet demonstrated consistent profitability despite strong revenue growth. Negative net income and a negative TTM EBITDA indicate that the current scale of operations is not reliably converting sales into earnings, limiting confidence in near-term earnings quality and durability.

Nugl (NUGL) vs. SPDR S&P 500 ETF (SPY)

Not enough price history over this period.

Market Cap
$1.30M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
6.5
Beta (1Y)
1.03
Revenue Growth
11.79%
EPS Growth
85.71%
Country
US
Employees
12
Sector
Communication Services
Sector Strength
60
Industry
Internet Content & Information

Nugl Business Overview & Revenue Model

Company Description

NUGL Inc. operates as a fully integrated medical cannabis business. The company manages cultivation and processing facilities, along with three retail dispensaries. Additionally, it holds various conditional licenses and distributes medical cannabis...

How the Company Makes Money

null

Nugl Financial Statement Overview

Summary

Strong financial turnaround with 80% TTM revenue growth, positive operating income, and robust cash flow generation. Balance sheet is deleveraging with a manageable debt-to-equity ratio of 0.74. The primary risk is that net income remains slightly negative, indicating the recovery is still in its early stages.

Income Statement

68Positive

Balance Sheet

72Positive

Cash Flow

78Positive
Financial statement breakdown
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.98M3.45M2.97M2.33M2.23M1.78M
Gross Profit1.89M1.68M1.36M1.67M1.07M702.92K
EBITDA503.50K412.76K227.07K-402.00K-1.92M-223.70K
Net Income-41.69K-48.40K-212.00K-829.00K-2.66M-752.00K
Balance Sheet
Total Assets4.25M4.07M3.92M3.83M4.16M5.55M
Cash, Cash Equivalents and Short-Term Investments226.41K121.55K141.68K191.75K86.58K134.32K
Total Debt1.45M1.52M1.61M1.55M2.03M2.72M
Total Liabilities2.30M2.25M2.19M2.47M2.37M2.92M
Stockholders Equity1.95M1.82M1.74M1.36M1.79M2.64M
Cash Flow
Free Cash Flow258.71K142.74K-37.94K207.20K-122.53K-226.66K
Operating Cash Flow340.92K212.65K-546245.99K-12.13K-185.93K
Investing Cash Flow-82.21K-69.91K-38.43K-38.79K-110.41K-40.73K
Financing Cash Flow-164.38K-162.87K-11.09K-102.02K-85.67K420.74K

Nugl Peers Comparison

Overall Rating

UnderperformOutperform
Sector (60)

Financial Indicators

NUGL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
NUGLNUGL65Neutral$1.30M6.50-2.30%―11.79%85.71%
Sector *60Neutral$48.67B4.58-11.27%4.14%2.83%-41.78%
LCFYLCFY38Underperform$1.26M-1.18-44.24%―――
ONFOONFO38Underperform$999.70K-0.01-3782.91%―-40.11%-212.67%
TCTC37Underperform$15.04M-0.16-102.96%―――

* Communication Services Sector Average

Performance Comparison

-100%-50%0%50%TCBAOSLCFYONFODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
NUGL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NUGLNugl ―――
TCTuanche Ltd0.69-15.79-95.82%
BAOSBaosheng Media Group Holdings Ltd0.12-2.24-95.08%
LCFYLocafy Ltd.0.70-2.51-78.16%
ONFOOnfolio Holdings, Inc.0.40-38.96-98.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 20, 2026